Therefore, IkB kinase inhibitors, bortezomib, or arsenic trioxide have been used in a variety of investigations to examine the effects of NFkB blockade on myeloma cell lines by promoting apoptosis [177]. The gene discussed is NFKB1; the disease is plasma cell myeloma.